Lyterian Therapeutics
Yohei Shibuya has over seven years of work experience in the field of biosciences. Yohei most recently worked at Lyterian Therapeutics as a Senior Scientist since April 2023. Prior to that, they held a Senior Scientist role at Restoration Biosciences from March 2022 to April 2023, and also served as a Scientist II from March 2022 to March 2023. Before joining Restoration Biosciences, Yohei Shibuya worked as a Postdoctoral Researcher at Stanford University School of Medicine from July 2016 to March 2022. Yohei also gained experience as a Postdoctoral Researcher at Dartmouth College from May 2015 to June 2016.
Yohei Shibuya completed their Bachelor's Degree in Agriculture, Agriculture Operations, and Related Sciences from Kyoto University in the year 2005. Yohei then pursued a Master's Degree in the same field from the same university, which they completed in 2007. Later on, Yohei proceeded to Dartmouth College, where they obtained a Doctor of Philosophy (Ph.D.) in Biochemistry in 2015.
This person is not in any offices
Lyterian Therapeutics
1 followers
Lyterian Therapeutics derives its name from the Greek word λυτήριος or lutḗrios, that defines the termination, healing, or end of disease. Disease resolution is coordinated by endogenous and exogenous agents that recruit cells and other effectors to the site of injury. We are inspired to learn from the logic that orchestrates homeostatic equilibria and fosters healing in response to disease. At Lyterian Therapeutics, we are committed to developing medicines for patients in need by co-opting physiologically relevant protein homeostatic mechanisms to regulate genetically validated targets.
Employees
1-10